ClearPoint Neuro Inc

ClearPoint Neuro Inc

CLPT

Get informed when a big investor buys or sells

+ Follow
Market Cap$379.97M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ClearPoint Neuro IncClearPoint Neuro Inc-12.9--154%13.33.4
$-11.04

Current Fair Value

183% downside

Overvalued by 183% based on the discounted cash flow analysis.

Share Statistics

Market cap$379.97 Million
Enterprise Value$407.96 Million
Dividend Yield$- (-)
Earnings per Share$-0.9
Beta1.29
Outstanding Shares29,546,889

Return

Return on Equity-154.27%ROE
Return on Assets-31.11%
Return on Invested Capital-31.55%

Valuation & Multiples

P/E Ratio-12.88P/E Ratio
PEG-22.01PEG
Price to Sales13.3Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue10.04
Enterprise Value to EBIT-15.41
Enterprise Value to Net Income-15
Total Debt to Enterprise0.16
Debt to Equity3.37Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 13, 2026
EPS Estimate
$-0.28
Average shareholder expectation
Revenue Estimate
$11.97 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 11, 2026
EPS Estimate
$-0.27
Average shareholder expectation
Revenue Estimate
$12.73 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.5508 7.83%
Total Calls335,900 4.61%
Total Puts185,000 8.42%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %45.88% 6.13%
Total Invested$118.30M 23.49%
Investors Holding124 2.00%

ESG Score

No data

About ClearPoint Neuro Inc